HealthEquity (NASDAQ:HQY) EVP Michael Henry Fiore Sells 2,354 Shares of Stock

HealthEquity, Inc. (NASDAQ:HQY) EVP Michael Henry Fiore sold 2,354 shares of the firm’s stock in a transaction that occurred on Friday, July 10th. The shares were sold at an average price of $95.00, for a total transaction of $223,630.00. Following the completion of the sale, the executive vice president owned 52,244 shares of the company’s stock, valued at approximately $4,963,180. This trade represents a 4.31% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Michael Henry Fiore also recently made the following trade(s):

• On Thursday, July 2nd, Michael Henry Fiore sold 2,470 shares of HealthEquity stock. The stock was sold at an average price of $95.00, for a total value of $234,650.00.
• On Friday, May 29th, Michael Henry Fiore sold 3,142 shares of HealthEquity stock. The shares were sold at an average price of $95.00, for a total value of $298,490.00.

HealthEquity Stock Performance

Shares of HQY opened at $94.50 on Wednesday. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The firm has a market cap of $7.90 billion, a PE ratio of 35.39, a P/E/G ratio of 1.61 and a beta of 0.21. HealthEquity, Inc. has a 12 month low of $72.76 and a 12 month high of $105.96. The stock has a fifty day moving average price of $87.97 and a 200-day moving average price of $84.64.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The firm had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities research analysts predict that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on HQY shares. Citizens Jmp upped their price objective on shares of HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a report on Monday, June 1st. KeyCorp reiterated an “overweight” rating on shares of HealthEquity in a research note on Tuesday, May 26th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a research report on Thursday, March 19th. JPMorgan Chase & Co. cut their price target on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating on the stock in a research note on Wednesday, March 18th. Finally, Weiss Ratings upgraded shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. Eleven analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, HealthEquity has a consensus rating of “Moderate Buy” and an average price target of $110.57.

Hedge Funds Weigh In On HealthEquity

Several institutional investors and hedge funds have recently modified their holdings of HQY. Sivia Capital Partners LLC purchased a new stake in shares of HealthEquity in the second quarter valued at approximately $306,000. Arrowstreet Capital Limited Partnership purchased a new position in shares of HealthEquity during the 2nd quarter valued at approximately $4,747,000. Marshall Wace LLP acquired a new stake in HealthEquity in the 2nd quarter valued at $5,483,000. Amundi increased its holdings in HealthEquity by 9.3% in the 2nd quarter. Amundi now owns 30,203 shares of the company’s stock worth $3,059,000 after acquiring an additional 2,574 shares in the last quarter. Finally, Jump Financial LLC purchased a new stake in HealthEquity in the 2nd quarter worth $449,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.